SANGAMO THERAPEUTICS, INC. (SGMOQ) Capital expenditures 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$102,000FY2025 · since FY2016: $732,000 → $102,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $102,000 | -61.8% |
| FY2024 | $267,000 | -98.7% |
| FY2023 | $21.2M | +4.9% |
| FY2022 | $20.2M | -13.3% |
| FY2021 | $23.3M | +58.2% |
| FY2020 | $14.7M | -28.8% |
| FY2019 | $20.7M | -52.0% |
| FY2018 | $43.1M | +1048.1% |
| FY2017 | $3.8M | +412.4% |
| FY2016 | $732,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More SGMOQ financial trends
SGMOQ RevenueSGMOQ Net incomeSGMOQ Net marginSGMOQ Gross profitSGMOQ Gross marginSGMOQ Operating incomeSGMOQ Operating marginSGMOQ Operating cash flowSGMOQ Free cash flowSGMOQ Return on equitySGMOQ Stock buybacksSGMOQ Dividends paidSGMOQ Total assetsSGMOQ Total liabilitiesSGMOQ Shareholders’ equitySGMOQ overview →